Epivir HBV (Lamivudine) — Patient Information (Australia)

Epivir HBV contains the active ingredient lamivudine, an antiviral medicine used to treat hepatitis B virus (HBV) infection. This page explains what the medicine is, how it works, how it is used, and important safety information. It is written for general information to help you understand your treatment options in an easy, patient-friendly way.

In Australia, medicines like Epivir HBV are regulated and supplied through pharmacies. Your exact suitability depends on your medical history, liver function, and viral test results.

Quick product facts

What is hepatitis B, and why treat it?

Hepatitis B virus infection affects the liver. Some people clear the virus, while others develop chronic hepatitis B. Over time, chronic HBV can lead to:

• Inflammation of the liver
• Fibrosis (scarring)
• Cirrhosis (advanced scarring)
• Hepatocellular carcinoma (liver cancer)

Antiviral medicines can reduce viral levels, improve liver markers, slow disease progression, and lower the risk of liver complications for appropriate patients.

Indications (when Epivir HBV is used)

Epivir HBV is used for the management of chronic hepatitis B. Use is typically based on liver blood tests (such as ALT/AST), HBV DNA levels, liver inflammation status, liver disease stage, and sometimes the presence of hepatitis B “HBeAg” (hepatitis B e antigen).

Treatment decisions can vary by patient. Some people may benefit from lifelong or long-term suppression; others may be able to stop after specific criteria are met. Your clinician will guide monitoring and whether continuing treatment remains appropriate.

Mechanism of action (how it works)

Lamivudine belongs to the class of antivirals called nucleoside analogues. HBV relies on its own enzymes to copy its genetic material (viral DNA). Lamivudine is converted inside cells into an active form that competes with natural building blocks used for viral DNA synthesis.

By blocking HBV DNA replication, lamivudine lowers HBV viral load. Over time, this can reduce liver inflammation and help protect liver tissue.

Important note: HBV can develop resistance to antivirals. Lamivudine has a known risk of resistance over time, which is why other medicines may be preferred in some patients (see “Alternative options” below).

Pharmacokinetics (how the body processes lamivudine)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination of a medicine. While individual responses vary, the general behaviour of lamivudine in the body includes:

• Absorption: Lamivudine is absorbed after oral dosing, with bioavailability that supports once-daily use in many HBV regimens.
• Distribution: It distributes into body tissues. It can reach concentrations in the liver where viral replication occurs.
• Metabolism: Lamivudine has limited metabolism.
• Elimination: It is largely eliminated via the kidneys. This means kidney function affects drug levels.

Because lamivudine clearance depends on renal function, your prescriber may recommend dose adjustments if you have kidney impairment.

Typical use and treatment goals

The goals of treatment with Epivir HBV are to:

• Suppress HBV replication (lower HBV DNA in blood tests)
• Improve liver inflammation (improve ALT/AST)
• Reduce progression to cirrhosis and related complications
• Maintain long-term control with appropriate monitoring

The response to treatment is usually assessed using follow-up blood tests and sometimes imaging (such as liver ultrasound) and fibrosis assessment. The exact schedule is individualised.

How to take Epivir HBV (timing and method)

Most adults take lamivudine once daily for HBV. Some patients may require different schedules depending on liver and kidney function and the treatment plan. Always follow the dosing instructions provided by your clinician and the directions on the medicine pack.

Timing

• Choose a consistent time each day to help you remember.
• You can take it with or without food.
• If you miss a dose, take it when you remember unless it is close to the next dose. Do not take double doses.

Practical tips

• Use a daily reminder (phone alarm, pillbox calendar, or pharmacy blister packs).
• If swallowing tablets is difficult, ask your pharmacist about available formulations or strategies.
• Keep a record of your doses if you are doing regular blood tests.

Food interactions

Food is not known to significantly reduce lamivudine effectiveness, so it is generally acceptable to take Epivir HBV with or without meals. However, maintaining routine meal timing may improve adherence and reduce stomach upset for some people.

If you experience nausea or abdominal discomfort, taking the dose with food may help.

Alcohol interactions and liver health

There is no “direct chemical” interaction between lamivudine and alcohol that is typically highlighted, but alcohol can be harmful in people with hepatitis B because it can worsen liver inflammation and scarring.

To support your liver while on HBV therapy:

• Limit alcohol or consider avoiding it, especially if you have elevated liver enzymes or fibrosis.
• Ask your clinician about your personal safe drinking level based on your liver condition.
• If alcohol use is difficult to control, consider speaking with a GP or alcohol support service—help is available in Australia.

Other medicine interactions

Lamivudine can interact with certain medicines, or those medicines can affect liver or kidney function. Always review your full medicine list with your healthcare professional.

Common interaction considerations

• Kidney-related medicines: Because lamivudine is cleared by the kidneys, some medicines that affect kidney function may require monitoring or dose adjustment.
• Other antiviral therapies: If you are taking additional HBV treatments, your clinician will select the best regimen and avoid unnecessary overlap.
• Medicines affecting the liver: Some drugs can stress the liver. While not all are contraindicated, your clinician may monitor more closely.
• Herbal products: Be cautious with supplements that may affect the liver (for example, some “liver detox” products). Inform your pharmacist and clinician.

If you start a new medicine (including over-the-counter products), check with a pharmacist to confirm it is compatible with lamivudine and safe for your liver and kidney status.

Dosing (general guidance)

Dosing depends on the reason for use, age, liver status, and particularly kidney function. Typical adult HBV regimens often involve once-daily dosing; however, exact strength and dose may vary by product presentation and patient needs.

For patient safety:

• Take exactly as directed on your prescription/dispensing label.
• If you have kidney impairment, your clinician may reduce the dose or extend dosing interval.
• Do not change dose or stop suddenly without medical advice, because stopping therapy may lead to HBV flare (a rebound increase in viral replication and liver inflammation).

Missed dose: If you miss a dose, take it as soon as you remember and continue your regular schedule. If it is almost time for the next dose, skip the missed dose—do not take two doses at once.

Safety profile (what to expect and when to get help)

Like all medicines, Epivir HBV can cause side effects. Many people tolerate lamivudine well. Some side effects are mild and temporary, while others require prompt medical attention.

Common or mild side effects

• Headache
• Nausea, stomach discomfort
• Fatigue
• Cough or upper respiratory symptoms (in some people)

Serious but less common risks

Seek medical advice urgently if you develop symptoms that could indicate serious complications. Examples include:

• Lactic acidosis: rare but serious condition. Symptoms may include unusual muscle pain, deep or rapid breathing, severe fatigue, abdominal pain, nausea/vomiting, or feeling very unwell.
• Severe liver problems or HBV flare: symptoms may include yellowing of skin/eyes (jaundice), dark urine, severe tiredness, right upper abdominal pain, or worsening nausea.
• Allergic reactions: swelling of face/lips, difficulty breathing, rash with blisters, or sudden severe hives.

Monitoring is important

• Your clinician may monitor ALT/AST (liver enzymes), HBV DNA, and sometimes kidney function.
• Regular follow-up helps detect inadequate response, resistance, or HBV flare early.

Resistance and treatment effectiveness

HBV resistance to lamivudine can develop. Resistance may lead to increased viral load and renewed liver inflammation. This is one reason clinicians may prefer other antivirals in many treatment settings.

Practical use tips (to get the best outcomes)

• Don’t miss doses: Consistent daily dosing helps control viral replication.
• Attend monitoring visits: Even if you feel well, blood tests are crucial.
• Avoid alcohol: Alcohol can increase liver damage risk.
• Check other medicines: Confirm new prescriptions, over-the-counter drugs, or supplements with your pharmacist.
• Plan ahead if stopping treatment: HBV flares can occur after stopping antivirals. A safe plan typically involves monitoring and timing.
• Vaccination and household protection: HBV can spread. Ensure close contacts are vaccinated if they are not already immune (discuss with your GP).

Alternative options for chronic hepatitis B

Several antiviral medicines are used for chronic hepatitis B. Choice depends on your HBV status, liver disease stage, prior treatment, resistance risk, kidney function, and guideline recommendations.

Examples of other treatments commonly considered include:

• Tenofovir-based therapies (often preferred in many guidelines for their high potency and resistance profile)
• Entecavir (a nucleoside analogue with a strong resistance profile compared with lamivudine)
• Interferon-based strategies in selected patients (not suitable for everyone)

Your clinician can explain which option best fits your individual situation and whether switching is recommended based on viral response and resistance risk.

Australia market and legal/regulatory context

In Australia, prescription medicines are supplied under strict regulations designed to support safe use. Availability may depend on your prescriber’s instructions, existing treatment history, and required monitoring.

Pharmacies must comply with Australian laws and professional obligations, including maintaining appropriate storage, dispensing processes, and patient counselling. Patients should only use medicines for the intended condition as advised by their healthcare professional.

Recent guidance and clinical considerations (high-level)

Treatment approaches for chronic hepatitis B continue to evolve, particularly around:

• Initial selection of therapy based on potency and resistance risk
• Monitoring schedules for viral load and liver function
• Management of treatment failure and resistance (including switching to alternatives)
• HBV flare prevention when adjusting or stopping treatment
• Special populations such as people with cirrhosis, co-infections, or kidney impairment

Many current practices favour antivirals with a stronger resistance profile compared with older options in appropriate patients. Your clinician can explain how these recommendations apply to your personal care plan.

Delivery, availability, and storage (Australia)

Availability of Epivir HBV can vary by stock and pharmacy suppliers. When ordering online, processing time depends on the pharmacy’s workflow, location, and courier service.

Delivery

• Delivery times depend on your location and the shipping service selected.
• You may receive tracking updates if offered by the pharmacy.
• Some areas may have longer delivery windows during peak periods.

Storage

• Store at the temperature stated on the medicine label (commonly below 25°C unless otherwise directed).
• Keep in the original packaging to protect from light and moisture.
• Keep out of reach of children.
• Do not use after the expiry date on the pack.

FAQ

1) Is Epivir HBV the same as Epivir (for HIV)?

Lamivudine is used in different medicines and dosing regimens depending on the condition. Epivir HBV is specifically intended for hepatitis B use, with an appropriate formulation/strength for HBV management. Do not substitute medicines or strengths without medical advice.

2) Can I take Epivir HBV with food?

Yes. Lamivudine can generally be taken with or without food. If you experience stomach discomfort, taking it with food may make you feel more comfortable.

3) What should I do if I miss a dose?

Take it when you remember, unless it is nearly time for your next dose. In that case, skip the missed dose and continue as usual. Do not take a double dose to “catch up.”

4) Will I feel better immediately?

Many people do not feel immediate changes because chronic hepatitis B can be relatively “silent.” Treatment success is assessed through blood tests (HBV DNA and liver enzymes) and sometimes imaging or fibrosis assessment.

5) How long will I need treatment?

Duration varies. Some people may stop under specific conditions after careful monitoring, while others require long-term or ongoing therapy. Your clinician will decide based on your response and risk factors.

6) What are HBV flares?

An HBV flare is a sudden rise in HBV activity, often with increased liver inflammation. Flares can occur when treatment is stopped or if resistance develops. Report symptoms such as jaundice, dark urine, right upper abdominal pain, or marked fatigue promptly.

7) Does lamivudine cure hepatitis B?

Epivir HBV helps suppress the virus and reduce liver damage risk, but it may not completely eliminate the virus in all people. The aim is long-term control and reducing progression.

8) Is it safe to drink alcohol while taking Epivir HBV?

Alcohol can worsen liver disease. Many people are advised to limit alcohol or avoid it. Your clinician can provide guidance based on your liver status.

9) Are there common warning signs I should watch for?

Seek medical attention if you develop signs of allergic reaction (swelling, trouble breathing), severe worsening illness, or symptoms suggestive of liver problems (yellow eyes/skin, dark urine, severe abdominal pain, persistent vomiting).

10) What if I have kidney problems?

Kidney function affects lamivudine levels. Your prescriber may adjust the dose and will likely recommend monitoring. Inform your healthcare professional if you have reduced kidney function or are on dialysis.

Important note

This information is a general guide. Personal medical advice should always come from your healthcare professional, who can consider your blood test results, current symptoms, co-existing conditions, and other medicines. If you have questions about Epivir HBV—such as suitability, monitoring, or managing side effects—speak with your pharmacist or GP.